Chargement en cours...
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
Bladder cancer is a leading cause of morbidity and mortality worldwide. Currently, immunotherapy has become a worthwhile therapy for bladder cancer. Tumor mutation burden (TMB) has been regarded as the most prevalent biomarker to predict immunotherapy. Bladder cancer is reported to have the third hi...
Enregistré dans:
| Publié dans: | Aging (Albany NY) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7041765/ https://ncbi.nlm.nih.gov/pubmed/32012118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102728 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|